Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

Women in Leadership: Barriers & Opportunities in the Life Science Industry

Allison Gaw, Executive Director, Corporate and Business Development at Chinook Therapeutics, discusses women in STEM, effective leadership, cross-border collaboration during COVID-19, the future of healthcare, and much more.

Impetus Digital

Highlighting Patient Voices, Workforce Well-Being & Health Literacy During & After the Pandemic

We explore the importance of health literacy, patient voices, and workforce wellbeing during COVID-19 with Deborah Collyar (Patient Advocates in Research), Cathryn Gunther (Population Health Alliance) & Catina O'Leary (Health...

Impetus Digital

- PMLiVE

NICE turns down bluebird bio’s gene therapy Zynteglo

Draft guidance does not recommend routine NHS funding for beta thalassaemia treatment

- PMLiVE

Lucid Group: A Community of Purpose

In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to...

Lucid Group Communications Limited

- PMLiVE

Challenges and opportunities during a changing environment for scientific communications – key themes from the ISMPP EU 2021 meeting

Nucleus Global’s Ashley Porter shares his thoughts from this year’s ISMPP EU 2021 meeting

Nucleus Global

- PMLiVE

AZ forecasts growth in 2021 after revenues surge in Q4

Most recent quarter is first 'for many years' in which product sales were in excess of $7bn

- PMLiVE

WHO backs AZ/Oxford COVID-19 vaccine, including in older adults

WHO's Sage panel also recommends a two-dose regimen given eight to 12 weeks apart

- PMLiVE

AZ partners with IDT Biologika to bolster manufacturing for COVID-19 vaccine in EU

AZ is looking to accelerate vaccine output in Q2 2021

- PMLiVE

Diana Evans joins Makara Health’s leadership team as director

Evans has both agency and in-house experience

- PMLiVE

A Community of Purpose

Why purpose is so important

Covid-19: how is it affecting prescribing patterns?

Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas

Wilmington Healthcare

- PMLiVE

ICER extends evaluation of Biogen’s aducanumab after FDA delay

FDA delayed its decision on potential Alzheimer's therapy to 7 June

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links